We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1.26B
AUM Growth
+$53.8M
Cap. Flow
+$3.44M
Cap. Flow %
0.27%
Top 10 Hldgs %
54.79%
Holding
48
New
2
Increased
18
Reduced
21
Closed
1

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$13M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$4.45M
3
IBM icon
IBM
IBM
+$3.15M
4
RTX icon
RTX Corp
RTX
+$3.12M
5
BIIB icon
Biogen
BIIB
+$3M

Top Sells

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$16.7M
2
MMM icon
3M
MMM
+$15.9M
3
ACN icon
Accenture
ACN
+$1.93M
4
AAPL icon
Apple
AAPL
+$1.57M
5
KO icon
Coca-Cola
KO
+$1.14M

Sector Composition

Rank Sector Weight
1 Technology 34.52%
2 Industrials 16.09%
3 Healthcare 15.47%
4 Consumer Staples 14.26%
5 Consumer Discretionary 6.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.57T
$94.5M 7.52%
2,626,004
-42,524
-2% -$1.57M
ORCL icon
2
Oracle
ORCL
$423B
$84.2M 6.69%
1,679,452
+44,305
+3% +$2.02M
MSFT icon
3
Microsoft
MSFT
$3.71T
$77.8M 6.19%
1,128,717
-7,573
-0.7% -$520K
RTX icon
4
RTX Corp
RTX
$301B
$76.7M 6.1%
998,618
+41,592
+4% +$3.12M
WMT icon
5
Walmart Inc
WMT
$890B
$69.5M 5.53%
2,755,674
+70,371
+3% +$1.79M
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.13T
$65.4M 5.2%
385,862
+26,779
+7% +$4.45M
NVO
7
Novo Nordisk
NVO
$209B
$62.9M 5%
2,934,006
+141,604
+5% +$2.86M
CSCO icon
8
Cisco
CSCO
$479B
$60.2M 4.79%
1,924,797
+36,912
+2% +$1.2M
CTSH icon
9
Cognizant
CTSH
$26B
$49.5M 3.93%
745,268
+39,198
+6% +$2.49M
VAR
10
DELISTED
Varian Medical Systems, Inc.
VAR
$48.3M 3.84%
468,428
-235
-0.1% -$22.6K
CHRW icon
11
C.H. Robinson
CHRW
$17.5B
$47.6M 3.79%
693,718
+2,540
+0.4% +$180K
PG icon
12
Procter & Gamble
PG
$339B
$45M 3.58%
516,731
-8,840
-2% -$779K
NKE icon
13
Nike
NKE
$61.9B
$39.7M 3.16%
672,601
+241,488
+56% +$13M
EXPD icon
14
Expeditors International
EXPD
$23.2B
$38.5M 3.06%
681,707
+49,999
+8% +$2.75M
BIIB icon
15
Biogen
BIIB
$30.7B
$37.3M 2.97%
137,562
+11,340
+9% +$3M
IBM icon
16
IBM
IBM
$224B
$36.1M 2.87%
245,243
+20,871
+9% +$3.15M
JNJ icon
17
Johnson & Johnson
JNJ
$625B
$35.2M 2.8%
266,210
-1,768
-0.7% -$226K
MDT icon
18
Medtronic
MDT
$112B
$34M 2.7%
382,854
-7,616
-2% -$642K
PEP icon
19
PepsiCo
PEP
$190B
$32.2M 2.56%
278,526
-2,382
-0.8% -$273K
KO icon
20
Coca-Cola
KO
$375B
$31.3M 2.49%
697,828
-25,692
-4% -$1.14M
ACN icon
21
Accenture
ACN
$108B
$31.2M 2.48%
251,910
-15,870
-6% -$1.93M
PII icon
22
Polaris
PII
$4.07B
$25.9M 2.06%
281,201
-11,148
-4% -$956K
BDX icon
23
Becton Dickinson
BDX
$48.2B
$24.2M 1.92%
127,071
-91,327
-42% -$16.7M
GOOGL icon
24
Alphabet (Google) Class A
GOOGL
$4.33T
$22.6M 1.8%
486,620
+45,940
+10% +$2.15M
MMM icon
25
3M
MMM
$94.3B
$20M 1.59%
114,938
-95,137
-45% -$15.9M

Similar funds

Saratoga Research & Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Saratoga Research & Investment Management held 48 positions worth $1.26B, up 4.5% from $1.2B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Saratoga Research & Investment Management's Q2 2017 filing shows 2 new, 18 increased, 21 reduced and 1 closed positions. Its largest new stake was Oneok: 5,270 shares worth $275K. The largest sale was Becton Dickinson, an estimated $16.7M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 35% a quarter earlier, followed by Industrials and Healthcare.

  • Saratoga Research & Investment Management's largest Q2 2017 buy was Oneok: 5,270 shares worth $275K.
  • Saratoga Research & Investment Management added most to Nike in Q2 2017, an estimated $13M increase.
  • Saratoga Research & Investment Management's biggest Q2 2017 reduction was Becton Dickinson, cutting an estimated $16.7M.
  • Saratoga Research & Investment Management fully exited Oneok Partners LP in Q2 2017, selling an estimated $289K.
  • Saratoga Research & Investment Management's ten largest holdings make up 55% of its $1.26B portfolio in Q2 2017.
  • Saratoga Research & Investment Management opened 2 new positions and closed 1 in Q2 2017.
  • Saratoga Research & Investment Management's portfolio value rose 4.5% quarter-over-quarter to $1.26B.

Based on Saratoga Research & Investment Management's 13F filing for Q2 2017, filed 27 Jul 2017.